Abstract
Schizophrenia has still unknown causes, although they may be related to dopaminergic hyperfunction and glutamatergic hypofunction, in addition to a possible link with neuroinflammation. Despite its imprecise origin, there are hypotheses about neurodevelopmental disorder leading to animal models based on interventions during this phase. One of these models is the treatment with methylazoxy…